Chanca Piedra Stone Breaker.

Citrate is excreted in urine where it binds free calcium and holds it in solution, supporting normal urinary mineral balance, and magnesium itself competes with calcium for oxalate. Chanca piedra is used traditionally on the same urinary axis.

Potassium citrate raises urine pH and urinary citrate, which keeps calcium and uric acid more soluble. It is the settled mineral partner for a botanical aimed at normal urinary crystal balance.

Pyridoxal phosphate is the cofactor for alanine glyoxylate aminotransferase, which routes glyoxylate to glycine instead of oxalate. Less endogenous oxalate means less urinary calcium oxalate load.

Phyllanthus extracts are rich in hydrolysable tannins and ellagitannins that bind ferric iron in the gut lumen into complexes the enterocyte cannot absorb. Space an iron dose away from the extract.

Potassium intake influences renal sodium handling and, when supplied as an organic salt, contributes alkali that raises urinary citrate excretion. Citrate in urine binds calcium and reduces the supersaturation that drives crystal formation. Both effects are urinary chemistry, which is a measurable marker rather than a clinical outcome.

Magnesium competes with calcium for oxalate in solution and forms a more soluble complex, so magnesium present in the gut lumen lowers the amount of free oxalate available to pair with calcium. Urinary magnesium likewise raises the concentration at which calcium oxalate begins to crystallise. This is solution chemistry with a long-established basis.

Dietary calcium taken with an oxalate-containing meal binds oxalate in the gut lumen as insoluble calcium oxalate, which leaves in the stool rather than being absorbed. Lower absorbed oxalate means lower urinary oxalate. Counterintuitively, timing calcium with meals rather than away from them is what produces this effect.

Ascorbate degrades to oxalate as one of its metabolic and non-enzymatic breakdown products, and high supplemental doses raise measured urinary oxalate excretion. That works against anything aimed at lowering urinary oxalate. The consideration applies to gram-level doses rather than to ordinary dietary intake.

Glycine is converted to glyoxylate, and glyoxylate is the immediate precursor that alanine-glyoxylate aminotransferase and lactate dehydrogenase route either back to safety or onward to oxalate. Large glycine loads therefore feed the oxalate pool. This is a pathway relationship worth naming rather than a reason to avoid glycine at ordinary intakes.

Calcitriol raises intestinal calcium absorption by inducing the transport machinery in the enterocyte, and higher absorbed calcium can raise urinary calcium excretion. Urinary calcium is one of the terms in calcium oxalate supersaturation. Anyone monitoring urinary mineral chemistry should count the vitamin D dose as part of the picture.

Some gut bacteria, most notably Oxalobacter formigenes and certain lactic acid bacteria, degrade oxalate in the intestinal lumen using oxalyl-CoA decarboxylase. Degrading oxalate before it is absorbed lowers what reaches the urine. Whether a given probiotic product carries oxalate-degrading capability is strain-specific and usually not stated.

Bicarbonate is an alkali load that raises urinary pH and urinary citrate excretion. Uric acid solubility rises steeply with pH while calcium phosphate solubility falls, so alkalinisation is not uniformly favourable across crystal types. It also carries a sodium load, and sodium raises urinary calcium.

Dandelion root and leaf have a long documented record of use for supporting normal urine volume, and the leaf is a notable potassium source. Combining two botanicals with the same traditional use raises total fluid turnover. Neither the combination nor either component's urinary effect is established at trial level here.

Marshmallow root is rich in mucilage polysaccharides that form a demulcent film on mucosal surfaces, which is the documented basis for its traditional use for urinary and throat comfort. That is a physical coating mechanism, unrelated to crystal chemistry. The pairing is a formulation convention.

Cranberry supplies A-type proanthocyanidins associated with reduced bacterial adhesion to urothelium, plus quinic and citric acids that alter urinary composition. It also contains oxalate, so a high cranberry intake adds to the oxalate load. Both directions are worth stating rather than only the favourable one.

Aerial parts of Phyllanthus niruri carry tannins and other polyphenols, and these chelate divalent cations in the gut lumen and lower their absorbed fraction. Zinc is among the minerals affected. Separating a zinc dose from a tannin-rich extract by a couple of hours removes the overlap.

Turmeric rhizome is among the higher-oxalate culinary plants, and gram-level powder intakes contribute measurably to oxalate load. A standardised curcuminoid extract carries far less of the root matrix than the whole powder does. Which one is in the formula decides whether this matters.

Silymarin is a flavonolignan complex used in formulas aimed at supporting normal liver function, and Phyllanthus species appear in the same category of traditional formula. The two are paired by convention rather than by a shared mechanism. No combination data supports the pairing.

Urine solute concentration is a function of solute load divided by water volume, so anything that raises fluid intake lowers supersaturation for every crystal type at once. Electrolytes support the fluid intake that makes that dilution sustainable. The sodium content of the blend is the part to watch, since sodium raises urinary calcium.